Aktis Oncology Q3 EPS $(0.54) Misses $(0.48) Estimate, Sales $3.905M Miss $4.016M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Misses
Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 97.18 percent increase over losses of $(19.18) per share from
Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 97.18 percent increase over losses of $(19.18) per share from the same period last year. The company reported quarterly sales of $3.905 million which missed the analyst consensus estimate of $4.016 million by 2.77 percent. This is a 147.31 percent increase over sales of $1.579 million the same period last year.